Encore Capital (ECPG) had the highest return between February 14, 2003 and July 1, 2003 by a small-cap US stock, returning 756.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Encore Capital (ECPG) | 2/14/2003 - 7/1/2003 | 756.19% |
Sohu (SOHU) | 2/14/2003 - 7/1/2003 | 405.53% |
Geron (GERN) | 2/14/2003 - 7/1/2003 | 321.52% |
Stratasys (SSYS) | 2/14/2003 - 7/1/2003 | 290.94% |
BioCryst Pharmaceuticals (BCRX) | 2/14/2003 - 7/1/2003 | 286.74% |
Omnicell (OMCL) | 2/14/2003 - 7/1/2003 | 263.64% |
STAAR Surgical (STAA) | 2/14/2003 - 7/1/2003 | 263.2% |
Vera Therapeutics (VERA) | 2/14/2003 - 7/1/2003 | 255.26% |
Ribbon Communications (RBBN) | 2/14/2003 - 7/1/2003 | 250% |
Spok (SPOK) | 2/14/2003 - 7/1/2003 | 230% |
Braskem SA Class A (BAK) | 2/14/2003 - 7/1/2003 | 206.98% |
Imax (IMAX) | 2/14/2003 - 7/1/2003 | 193% |
OneSpan (OSPN) | 2/14/2003 - 7/1/2003 | 191.49% |
Tat Techno (TATT) | 2/14/2003 - 7/1/2003 | 177.62% |
USANA Health Sciences (USNA) | 2/14/2003 - 7/1/2003 | 171.63% |
NVE (NVEC) | 2/14/2003 - 7/1/2003 | 167.23% |
Vericel Corp Ord (VCEL) | 2/14/2003 - 7/1/2003 | 166.67% |
Avadel Pharmaceuticals (AVDL) | 2/14/2003 - 7/1/2003 | 163.77% |
CEVA (CEVA) | 2/14/2003 - 7/1/2003 | 158.06% |
Cantaloupe (CTLP) | 2/14/2003 - 7/1/2003 | 147.37% |
Celldex Therapeutics (CLDX) | 2/14/2003 - 7/1/2003 | 145.54% |
Global Industrial (GIC) | 2/14/2003 - 7/1/2003 | 139.31% |
Oruka Therapeutics (ORKA) | 2/14/2003 - 7/1/2003 | 135.53% |
eGain (EGAN) | 2/14/2003 - 7/1/2003 | 130% |
Stagwell (STGW) | 2/14/2003 - 7/1/2003 | 129.22% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
